Glanbia plc
GLAPY
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.95B
Close$
Share Statistics
| Market cap | $5.95 Billion |
|---|---|
| Enterprise Value | $6.78 Billion |
| Dividend Yield | $2.28 (2.33%) |
| Earnings per Share | $3.65 |
| Beta | 0.5 |
| Outstanding Shares | 48,302,645 |
Return
| Return on Equity | 18.73% |
|---|---|
| Return on Assets | 8.89% |
| Return on Invested Capital | 21.24% |
Valuation & Multiples
| P/E Ratio | 21.84 |
|---|---|
| PEG | 42.3 |
| Price to Sales | 0.73 |
| Price to Book Ratio | 3.16 |
| Enterprise Value to Revenue | 0.83 |
| Enterprise Value to EBIT | 10.98 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.64 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$3.51
Average shareholder expectationRevenue Estimate
$2.02 B
Average shareholder expectationNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
$3.93
Average shareholder expectationRevenue Estimate
$2.15 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Glanbia plc
4,963 employees
CEO: Hugh McGuire Finance Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-...